Trials / Completed
CompletedNCT00368394
Dose-Exposure-Response in Type 1 Diabetes Mellitus
Dose-Exposure-Response Relationship of Insulin Glulisine (HMR1964) in Subjects With Type 1 Diabetes Mellitus Assessed With the Euglycemic Clamp Technique Using the Biostator (TM)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 18 (planned)
- Sponsor
- Sanofi · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
To investigate the dose-exposure-response relationship of insulin glulisine (HMR1964) after single subcutaneous injections of 0.075, 0.15 and 0.3 U/kg body weight with the euglycaemic clamp technique using the Biostator (TM).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Insulin glulisine |
Timeline
- Start date
- 2004-01-01
- First posted
- 2006-08-24
- Last updated
- 2006-08-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00368394. Inclusion in this directory is not an endorsement.